The APGALLA brand, founded in 2015 (Switzerland), from 2951 sister brands and 17477 competing brands. The APGALLA brand is owned by NOVARTIS N, a company listed in Zurich. The International Securities Identification Number (ISIN) of NOVARTIS N is CH0012005267. APGALLA belongs to the Drug Manufacturers business sector.

APGALLA is a brand of NOVARTIS N (NOVN) Share price

International deposit : 2015 Business sector Drug Manufacturers

Share price and profitability of the share NOVARTIS N (APGALLA)

Buy NOVARTIS N share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested CHF 86.50

Portfolio valuation
NOVARTIS N (APGALLA) over 5 years* CHF 100.09

Stock market history NOVARTIS N (APGALLA)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
NOVARTIS N

DTX PHARMA
DTX PHARMA
Ataxion
Ataxion
Cadent Therapeutics
Cadent Therapeutics
Amblyotech
Amblyotech
The Medicines Company
The Medicines Company
CellforCure
CellforCure
See more brands of NOVARTIS N

Rival brands
APGALLA

POINT BIOPHARMA
POINT BIOPHARMA
Icosavax
Icosavax
OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
LACTAID
LACTAID
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS